Chronix Blood Test Can Predict Cancer Patients’ Response to Immunotherapy, Study Shows
News
A blood-based cancer test has shown promise in predicting how solid-cancer patients will respond to immunotherapy, according to the test’s developer, Chronix Biomedical. The study, “Tumor Cell-Free DNA Copy Number Instability ... Read more